The apparent diffuse coefficient (ADC) may correlate with the treatment response to chemotherapy/radiotherapy in solid tumors. Our aim was to determine the inter- and intra-observer reproducibility of ADC measurements in primary esophageal squamous cell carcinoma (ESCC). ADCs were blindly measured in 31 patients diagnosed with ESCC by two observers before treatment (pre-ADC) and after 5th fraction radiotherapy (intra-ADC) twice with a 2-week interval. The mean pre-ADC of primary tumors was 1.25±0.22 and 1.27±0.23 (in 10-3mm2/s) from observer A for measurements 1 and 2, respectively, and the intra-observer measurements were -0.02 bias vs. -0.13-0.09 limits of agreement. From observer B, the mean pre-ADC varied between 1.25±0.23 and 1.27±0.23 (in 10-3mm2/s) for measurements 1 and 2, respectively, and intraobserver measurements were -0.02 bias vs. -0.17~0.16 limits of agreement. The mean pre-ADC of primary tumors was 1.26±0.24 (in 10-3mm2/s) from observers A and B, and inter-observer measurements were 0.01 bias vs. -0.09-0.09 limits of agreement, revealing a low inter-observer variance. Similar measurements of the intra-SD parameters showed that the pre- and intra-ADC of primary tumors differed significantly. Thus ADC measurements may have sufficient inter-observer and intraobserver reproducibility to measure primary tumor responses to treatment, and the ADCs before and during treatment differed.
CITATION STYLE
Ye, Z., Fang, J., Dai, S., Xie, T., Wang, F., Wang, Z., … Wang, Y. (2017). Inter- and intra-observer reproducibility of ADC measurements in esophageal carcinoma primary tumors. Oncotarget, 8(54), 92880–92889. https://doi.org/10.18632/oncotarget.21639
Mendeley helps you to discover research relevant for your work.